Skip to content

Behavioral Activation for Depression Through Virtual Reality

Behavioral Activation for Depression Through Virtual Reality

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05138744
Enrollment
8
Registered
2021-12-01
Start date
2021-12-05
Completion date
2022-02-20
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

Evaluate the effectiveness of a brief, virtual reality intervention for depressed mood

Interventions

OTHERBehavioral activation using virtual reality

The investigators will encourage behavioral activation (increase in the number and time of conducted activities) situating the person in motivating situations using virtual reality

Sponsors

Universitat Jaume I
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single case design (multiple baselines)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient Health Questionnaire - 9 (measure of depression) over 9 * Positive and Negative Affect Schedule (measure of positive and negative affect): positive affect score below 24 * Age over 18 years * Signs informed consent

Exclusion criteria

* Completes more than 20% of evaluations retrospectively (not the day they are assigned) * Has a severe mental health disorder as evaluated with the MINI International Neuropsychiatric Interview * Does not sign the informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in Behavioral activationChange through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline vs posttreatment)In a scale from 0 (not at all) to 6 (completely), to what extent were you satisfied with what you did today?

Secondary

MeasureTime frameDescription
Change in MoodChange through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)In a scale from 0 (completely sad) to 100 (completely happy), how did you feel today?
Change in DepressionChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)In a scale from 0 (not at all) to 3 (completely), how was your level of depression today?
Change in Positive affectChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)In a scale from 1 (not at all) to 5 (completely), how was your positive affect today?
Change in Negative affectChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)In a scale from 1 (not at all) to 5 (completely), how was your negative affect today?
Change in Activity levelChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)In a scale from 0 (minimum) to 100 (maximum), what was your activity level today?

Contacts

Primary ContactDesirée Colombo, PhD
dcolombo@uji.es964 387648
Backup ContactCarlos Suso, PhD
susor@uji.es

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026